OTC: PBIGF - Paradigm Biopharmaceuticals Limited

六个月盈利: +121.59%
股息率: 0.00%
部门: Healthcare

促销时间表 Paradigm Biopharmaceuticals Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета aud
Сайт https://www.paradigmbiopharma.com
Цена ао 0.3807
每日价格变化: 0% (0.3807)
每周价格变化: 0% (0.3807)
每月价格变化: +8.77% (0.35)
3个月内价格变化: +170.96% (0.1405)
六个月内的价格变化: +121.59% (0.1718)
每年价格变化: +63.25% (0.2332)
3年内价格变化: -60.55% (0.9649)
5年内价格变化: -87.31% (3)
年初以来价格变化: +170.96% (0.1405)
所有参数

低估

姓名 意义 年级
P/S 1207.21 1
P/BV 3.34 5
P/E 0 0
EV/EBITDA -1.06 0
全部的: 3.38

效率

姓名 意义 年级
ROA, % -91.65 0
ROE, % -112.45 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0041 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -97.79 0
盈利能力 Ebitda, % 385.35 10
盈利能力 EPS, % 209.58 10
全部的: 8
更多详情

机构 体积 分享, %
Vanguard International Stock Index-Total Intl Stock Indx 3456896 0.99
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 2117667 0.6
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 1055062 0.3
Vanguard International Stock Index-Pacific Stock Index 392059 0.11
SPDR Portfolio Developed World ex-US ETF 169911 0.05
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF 105574 0.03
Vanguard Intl Equity Index - Total World Stock Index Fd 71921 0.02
DFA Asia Pacific Small Company Series 59638 0.02
Vanguard World Fund-Vanguard ESG International Stock ETF 43440 0.01



导师 职称 支付 出生年份
Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC Founder, MD & Executive Chairman 1.17M 1959 (66 年)
Dr. Donna L. Skerrett M.D., MS Chief Medical Officer and Executive Director 843.69k 1957 (68 年)
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A. Company Secretary & CFO N/A
Dr. Ravi Krishnan Chief Scientific Officer N/A
Mr. Simon White Director of Investor Relations N/A
Dr. Michael Imperiale Global Head of Drug Safety & MPS N/A
Ms. Beverley Huttmann Commercial Head N/A
Ms. Michelle Coffey Global Head of Regulatory Affairs N/A
Dr. Mukesh Ahuja Global Clinical Head of OA N/A

地址: Australia, Melbourne, 500 Collins Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.paradigmbiopharma.com